When was Alida Biosciences founded?

Alida Biosciences was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is Alida Biosciences located?

Alida Biosciences is headquartered in San Diego, United States.

How many employees does Alida Biosciences have?

As of Jun 30, 2026, the latest employee count at Alida Biosciences is 18.

Is Alida Biosciences a funded company?

Alida Biosciences is a funded company, having raised a total of $11.5M across 8 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 17, 2021.

When was the latest funding round of Alida Biosciences?

Alida Biosciences' latest funding was a $***** Grant (prize money) round on Dec 04, 2025, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.74B in funding in 2026 to date.

Where does Alida Biosciences rank among its competitors?

Alida Biosciences ranks 4th amongst 15 active competitors, of which 6 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Cofactor Genomics, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of Alida Biosciences?

Alida Biosciences' top competitors include Veracyte, HAYA Therapeutics and Cofactor Genomics. Among them, Cofactor Genomics secured the most recent funding round in December, 2025.

Alida Biosciences - 2026 Company Profile, Team, Funding & Competitors

Alida Biosciences is a series A company based in San Diego (United States), founded in 2020 by Byron Purse. It operates as a Provider of technology for RNA analysis to improve human health. Alida Biosciences has raised $11.5M in funding from Genoa Ventures. The company has 15 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Veracyte, HAYA Therapeutics and Cofactor Genomics.

Company Details

Provider of technology for RNA analysis to improve human health. The company offers new technologies in RNA biology to develop new medical treatments and diagnostic assays.

Website: www.alidabio.com/
Email ID: *****@alidabio.com

Key Metrics

Founded Year

2020

Location

San Diego, United States

Stage

Series A

Total Funding

$11.5M in 8 rounds

Latest Funding Round

Grant (prize money), Dec 04, 2025, $*****

Investors

Genoa Ventures & 3 more

Ranked

4^th among 15 active competitors

Employee Count

18 as on Jun 30, 2026

Similar Companies

Veracyte & 18 more

View Alida Biosciences' full profile

Alida Biosciences is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Alida Biosciences Inc. CIN: 853573915 , United States, Active	Dec 31, 2019	-	17 (As on Dec 31, 2024)	-

Alida Biosciences has raised a total funding of $11.5M over 8 rounds. Its first funding round was on Aug 17, 2021. Its latest funding round was a Grant (prize money) round on Dec 04, 2025 for $*****. 1 investor participated in its latest round. Alida Biosciences has 4 institutional investors.

Here is the list of recent funding rounds of Alida Biosciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 04, 2025	4968907	Grant (prize money)	6116765	7427512	8435309	6027067
Mar 04, 2025	9778851	Grant (prize money)	8878238	1378706	4525995	HHS
Jun 07, 2024	4169576	Series A	3734238	4297440	Genoa Ventures	FusionX Ventures & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Alida Biosciences's funding rounds and investors

The founders of Alida Biosciences is Byron Purse.

Here are the details of Alida Biosciences' key team members:

Byron Purse: Co-Founder of Alida Biosciences.
Contact Info: 1 email address

View details of Alida Biosciences's Founder profiles and Board Members

Alida Biosciences' employee count trend

Alida Biosciences has 18 employees as of Jun 26. Here is Alida Biosciences's employee count trend over the years:

Employee count trend for Alida Biosciences

Uncover Alida Biosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alida Biosciences include Veracyte, HAYA Therapeutics and Cofactor Genomics. Here is the list of Top 10 competitors of Alida Biosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Veracyte 2008, San Francisco (United States), Public	Developer of genomics-based diagnostics for cancer	$67.9M	Domain Associates, General Electric & 11 others	61/100
2nd	HAYA Therapeutics 2017, Lausanne (Switzerland), Series A	Developer of RNA-based therapies for treating heart diseases	$90M	Earlybird, Humboldt Fund & 15 others	58/100
3rd	Cofactor Genomics 2009, San Francisco (United States), Series A	Developer of diagnostic assays using RNA sequencing	$26.2M	7percent Ventures, Menlo Ventures & 18 others	55/100
4th	Alida Biosciences 2020, San Diego (United States), Series A	Provider of technology for RNA analysis to improve human health	$11.5M	Vertical Venture Partners, Genoa Ventures ... & 2 others	54/100
5th	Novigenix 2014, Epalinges (Switzerland), Series B	Developer of technology for cancer precision medicine	$20M	Eurostars, Europa	52/100
6th	Cajal Neuroscience 2020, Seattle (United States), Series A	Developer of drugs for neurodegenerative disease based on genetic screening, and multi-omics approach	$96M	The Column Group, Lux Capital & 6 others	46/100
7th	Isoma Diagnostics 2017, Philadelphia (United States), Funding Raised	Molecular diagnostic tests for stratification of Glioblastoma	-	Ben Franklin Technology Partners	29/100
8th	Biomedica Immunoassays 1992, Vienna (Austria), Unfunded	Developer of ELISAs kits for detecting circulating microRNAs	-	-	28/100
9th	PeriRx 2008, Broomall (United States), Funding Raised	Developer of saliva-based risk stratification test for oral cancer	-	BioAdvance, Ben Franklin Technology Partners	27/100
10th	Nova Satra 2014, Singapore (Singapore), Seed	Provider of non-invasive diagnostic tests for cancer	$2M	Inex	26/100